HTA18 Impact of The Use of Cost-Effectiveness Analysis (CEA) on Patient Access to Medicines: A Comparison of CEA vs Non-CEA Markets
Abstract
Authors
G Katsikostas-Michopoulos C Alleman A Azough S Hickson A Griffin D Rollmann J Mckendrick